The Cooper Companies, Inc. (COO) Revenue by Segment & Business Profile
Cooper Vision was 67.2% of The Cooper Companies, Inc.'s revenue across the 2 lines it reports, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
COOThe Cooper Companies, Inc.Follow COO — free
—
Price chart with a free account
- Market cap
- 11.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Dec, in 39 days
What the company does
The Cooper Companies, Inc. is a medical instruments & supplies company in the healthcare sector. In its SEC filings it reports 2 business lines: Cooper Vision (67%), Cooper Surgical (33%). Trailing twelve-month revenue: $4.2 billion as of 2026-07-31.
Roles we read
from the filings, not the sector label- Dental / orthodontic supplies
- Medical consumables / supplies
Revenue by geography
latest quarter · company segment note| Region | Revenue | Share | y/y |
|---|---|---|---|
| United States | 520M | 48.7% | +0.6% |
| Europe | 358M | 33.5% | +4.2% |
| Rest Of World Excluding United States And Europe | 189M | 17.8% | -5.9% |
The Cooper Companies, Inc. — questions
- What does The Cooper Companies, Inc. do?
- The Cooper Companies, Inc. is a medical instruments & supplies company in the healthcare sector. In its SEC filings it reports 2 business lines: Cooper Vision (67%), Cooper Surgical (33%). Trailing twelve-month revenue: $4.2 billion as of 2026-07-31.
- How does The Cooper Companies, Inc. make money?
- By the lines it reports in its SEC filings: Cooper Vision 67.2%, Cooper Surgical 32.8% of revenue.
Every figure on this page comes from The Cooper Companies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.